<DOC>
	<DOCNO>NCT02122731</DOCNO>
	<brief_summary>To evaluate antihypertensive effect amiloride add triple antihypertensive therapy patient resistant hypertension ( RH ) type 2 diabetes mellitus ( T2DM )</brief_summary>
	<brief_title>Amiloride Resistant Hypertension</brief_title>
	<detailed_description>The primary objective study evaluate antihypertensive effect amiloride add triple antihypertensive treatment patient resistant hypertension type 2 diabetes mellitus open-labelled , non- control non-randomized interventional study . The secondary objective evaluate additional effect amiloride : - Urinary albumin excretion - Blood pressure control , many patient reach blood pressure control amiloride add previous triple antihypertensive treatment . - Plasminogen plasmin excretion ( ENaC activity ) micro-and macroalbuminuric patient cohort . - Urokinase plasminogen activator ( uPA ) activity</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Amiloride</mesh_term>
	<criteria>diagnose resistant hypertension ( average daytime BP &gt; 130and/or &gt; 80 mmHg ambulatory monitor spite treatment 3 antihypertensive drug include diuretic angiotensin coverting enzyme inhibitor ( AECi ) angiotensin recpetor blocker ( ARBs ) third optional , optimal dosage . type 2 diabetes prior participant randomize control trial spironolactone , washout period minimum two week ( NCT01062763 ) Office blood pressure ( BP ) &gt; 180/110 mmHg daytime average BP ambulatory monitoring &gt; 170/85 mmHg heart failure ( NYHA IIIIV ) Cardiac arrythmia HbA1C &gt; 10 % severe dyslipidemia know sign secondary hypertension estimate glomerular filtration rate ( eGFR ) &lt; 50ml/min per 1.73 m2 prior intolerance spironolactone amiloride fertility without oral contraception pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>antihypertensive therapy</keyword>
	<keyword>amiloride</keyword>
	<keyword>add-on</keyword>
	<keyword>resistant hypertension</keyword>
	<keyword>blood pressure control</keyword>
	<keyword>type 2 diabetes mellitus ,</keyword>
	<keyword>microalbuminuria .</keyword>
</DOC>